While RBL1 and RBL2 are infrequently mutated in human cancers, RB1 mutations are prevalent across various cancer types, such as retinoblastoma, osteosarcoma, pinealoma, and melanoma [6]. This evidence concerns the gene RB1 and osteosarcoma.